General practitioners (GPs) and nurse practitioners will be able to start medical treatment for adults with ADHD, following decisions by Medsafe and Pharmac.

Hon Matt Doocey, Associate Health Minister with responsibility for Rural Health and Minister for Mental Health, is visiting rural communities to hear about local health care and how the Government can ...

About Te Pae Mahutonga Te Pae Mahutonga is a Māori name for the Southern Cross constellation. The 4 central stars of the Southern Cross represent 4 key tasks of health promotion: mauriora (cultural ...

The New Zealand Health Survey (NZHS) provides information about the health and wellbeing of adults and children in New Zealand. These tables present key health indicators from all years of the ...

Overview In April 2025, the Government approved a transitional access policy for cancer patients receiving, or about to receive, treatment with newly publicly funded medicines within the same private ...

The Government is reviewing health workforce regulation to improve New Zealanders’ timely, quality access to healthcare. We have an opportunity to put patients at the centre, modernise and streamline ...

Subscribe to the Public Health Agency quarterly newsletter, Public Health Matters. We will be sharing the latest about how the Agency is working across the health system and beyond to improve the ...

Following a change of Minister, the Ministry of Health | Manatū Hauora, produces a Briefing to the Incoming Minister of Health, as is usual practice. This briefing provided the incoming Minister of ...

In February 2024, the High Court directed the Director-General of Health to assess whether each of the 14 directions to fluoridate one or more water supplies made in 2022 were, in terms of section 5 ...

The 2014 report from the Royal Society of New Zealand north_east (RSNZ) and the 2021 report from the Office of the Prime Minister’s Chief Science Advisor north_east (OPMCSA) on the risks and benefits ...

The consultation on safety measures for the use of puberty blockers in young people with gender-related health needs closed on 20 January 2025. We will now consider submissions.BackgroundThe ...

Purpose This position statement accompanies the release of an evidence brief which examines the safety and long-term impacts of puberty blockers when used in the context of gender-affirming care. View ...